Facebook Pixel Code
About Sickkids
About SickKids

Daniel Morgenstern, MD

The Hospital for Sick Children
Staff Physician, Solid Tumour Section
Haematology/Oncology

Director, New Agent and Innovative Therapy Program (NAIT)
Haematology/Oncology

Director, MIBG Therapy Program
Haematology/Oncology

Research Institute
Project Investigator
All

University of Toronto
Department of Paediatrics
Assistant Professor


Phone: 416-813-7654 x 227565
Fax: 416-813-5327
Email: daniel.morgenstern@sickkids.ca

Brief Biography

Dr. Morgenstern undertook his undergraduate medical training at the University of Cambridge (UK) and graduated in 2001 with combined PhD and MB BChir degrees. He then completed paediatric training at University College London Hospital and subspecialty training in paediatric oncology at Great Ormond Street Hospital for Children in London. He qualified for membership of the Royal College of Paediatrics and Child Health in 2005 and received his Certificate of Completion of Specialist Training (CCST) in paediatrics and paediatric oncology in 2011. He was an academic clinical lecturer based at UCL Institute of Child Health and undertook research relating to cancer immunology. Morgenstern subsequently undertook a fellowship in drug development at the Royal Marsden Hospital, Sutton, UK and then moved to SickKids as the first Sears Foundation / Garron Cancer Centre Fellow in Neuroblastoma in 2012.

In 2013, Morgenstern moved back to the UK to take up a role as consultant in paediatric oncology at Great Ormond Street Hospital and Honorary Senior Lecturer at UCL Institute of Child Health, where he was clinical lead for neuroblastoma and for the autograft program. He was also Chair of the UK Children’s Cancer and Leukemia Group (CCLG), Neuroblastoma Special Interest Group and an active member of SIOPEN, the European collaborative group for neuroblastoma research. He remains a member of the UK National Paediatric Autograft Panel.

Morgenstern returned to SickKids in September 2016 as Staff Oncologist with a particular interest in neuroblastoma and drug development.

Academic Background

Undergraduate training and PhD
University of Cambridge, 1993-2001

Paediatric training
University College London Hospitals, 2002-2007

Higher specialist training in paediatric oncology and academic clinical lecturer
Great Ormond Street Hospital and UCL Institute of Child Health, 2007-11

Clinical Care Activities

Morgenstern’s clinical activities are focused on the care of children with solid tumours and in particular neuroblastoma. He is also active in the Novel and Innovative Therapies (NAIT) program.

Research Interests

  • Novel therapies for high-risk neuroblastoma.
  • Early phase clinical trials.

Achievements

Brigid Leventhal Merit Award, American Society of Clinical Oncology, 2013.

Publications

For full list of publications, please see PubMed.